HEALSTONE
Live / Registered — Registered (as of 26 Nov 2024)
What this means for you
Registered since 26 Nov 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97799916
- Registration number
- 7581395
- Mark type
- Design + words
- Filed
- 17 Feb 2023
- Published for opposition
- 19 Dec 2023
- Registered
- 26 Nov 2024
- Attorney of record
- John Davis
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Medical diagnostic reagents; Medical diagnostic reagents for the analysis of body fluids; Pregnancy testing preparations; Diagnostic preparations for medical purposes; Medical diagnostic reagents and assays for testing of body fluids
- Class 009 — Scientific and electric apparatus: Medical laboratory research instruments for detecting nucleic acids, testing DNA or RNA, and virus detection
- Class 010 — Medical apparatus: Medical diagnostic apparatus for testing DNA and RNA samples; Medical diagnostic apparatus for testing for viruses; Medical diagnostic instruments for the analysis of body fluids
Owner
- Healgen Scientific, Houston, TX, US
- Healgen Scientific, Houston, TX, US
- Healgen Scientific, Houston, TX, US
Prior registrations
Prosecution history
- 26 Nov 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 26 Nov 2024 — REGISTERED-PRINCIPAL REGISTER
- 24 Oct 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 Oct 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Oct 2024 — ASSIGNED TO LIE
- 18 Jul 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 Apr 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 Apr 2024 — NON-FINAL ACTION E-MAILED
- 18 Apr 2024 — SU - NON-FINAL ACTION - WRITTEN
- 21 Mar 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Feb 2024 — USE AMENDMENT FILED
- 21 Mar 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 Feb 2024 — TEAS STATEMENT OF USE RECEIVED